AP
STE icon

Antipodes Partners’s Steris STE Stock Holding History

Antipodes Partners’s Portfolio STE Stock Details STE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$128K Sell
610
-2
-0.3% -$429 ﹤0.01% 101
2026
Q1 		$135K Buy
612
+260
+74% +$63.6K ﹤0.01% 89
2025
Q4 		$89.2K Hold
352
– – ﹤0.01% 91
2025
Q3 		$87.1K Buy
352
+92
+35% +$22K ﹤0.01% 88
2025
Q2 		$62.5K Sell
260
-273
-51% -$63.6K ﹤0.01% 80
2025
Q1 		$121K Buy
+533
New +$117K ﹤0.01% 69

Other funds holding STE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $4.15B AUM 31.06% 1-Year Est. Return

Antipodes Partners's STE Position: Q2 2026 in Review

Antipodes Partners reduced its Steris (STE) stake by 0.33% in Q2 2026, selling an estimated $429 and leaving 610 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #101.

Antipodes Partners first reported a position in STE in Q1 2025 and has held it in 6 quarters since. The position peaked at $135K in Q1 2026. 460 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Antipodes Partners held 610 shares of Steris worth $128K as of Q2 2026.
  • Antipodes Partners sold 2 Steris shares in Q2 2026, an estimated $429.
  • Steris made up ﹤0.01% of Antipodes Partners's portfolio in Q2 2026, its #101 holding.
  • Antipodes Partners first reported a position in Steris in Q1 2025 and has held it in 6 quarters since.
  • Antipodes Partners's Steris position peaked at $135K in Q1 2026.
  • 460 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.